Facts

• Segment: Healthcare
• Country: China
• Founded: 2017
• Website: https://www.chengtian-tech.com

Profile sections

• Summary
• Market context
• Facts
• Funding
• Investors
• Context / Market Position
• Events
• Team
• Sources

Summary

Chengtian Technology, also known through RoboCT, develops robotic exoskeletons and intelligent rehabilitation equipment. Its products support walking assistance, rehabilitation training and mobility aid use for hospitals, elderly users and people with movement impairment.

Market context

Chengtian Technology is one of the clearer exoskeleton-platform companies in China with both medical and consumer commercialization traction. Its expansion beyond rehab into consumer and industrial assistance gives it broader relevance than a narrow clinical-device vendor. Chengtian Technology develops exoskeleton robots and intelligent assistive systems for rehabilitation, eldercare, consumer mobility, and industrial support, with focus on exoskeleton algorithms, key components, human-machine interaction, sensing, and cloud-connected platforms.

• Capability: Lower-limb exoskeleton systems
• Capability: Human-machine interaction
• Capability: Intelligent sensing
• Capability: Motion assistance
• Capability: Rehabilitation robotics
• Capability: Consumer mobility support
• Strategic position: Exoskeleton robotics
• Strategic position: Assistive robotics
• Strategic position: Rehabilitation and mobility systems

Facts

• Website: https://www.chengtian-tech.com
• HQ: Hangzhou, China
• Founded: 2017
• Segment: Healthcare
• Known funding rounds: 3

Funding

• 2026-03-05 - Series B+ - $14M - Chengtian Technology completes B+ financing round - source: 36kr.com
• 2025-03-27 - Series B - $14M - Chengtian Technology (程天科技) completes near-RMB 100M Series B financing - source: m.36kr.com
• 2021-03-30 - Series A - Chengtian Technology (程天科技) raises Round A financing - source: equalocean.com

Investors

• ABC Capital - Lead - Vc - 1 funding event - first seen 2026-03-05
• Agricultural Bank Capital - Lead - Vc - 1 funding event - first seen 2026-03-05
• Hangzhou Capital - Participant - Vc - 1 funding event - first seen 2026-03-05
• Inovance Industry Investment - Participant - Unknown - 1 funding event - first seen 2026-03-05
• Wuxi Venture Capital - Lead - Vc - 1 funding event - first seen 2025-03-27
• LanChi Ventures - Lead - Vc - 1 funding event - first seen 2021-03-30

Exoskeleton rehabilitation robot company

Chengtian Technology develops exoskeleton robots and intelligent rehabilitation equipment for elderly care, disability support and clinical rehabilitation.

• Target environment: Rehabilitation clinics, eldercare settings, hospitals, home rehabilitation and assistive mobility environments.
• Deployment model: Rehabilitation robot and assistive equipment supply through medical, household and care-oriented product channels.
• Customer context: Rehabilitation providers, elderly users, disabled patients, clinics, hospitals and care institutions.
• Workflow context: Gait rehabilitation, mobility assistance, exoskeleton support, training therapy and intelligent rehabilitation programs.
• Commercial maturity: Commercial rehabilitation robotics company with exoskeleton and intelligent rehabilitation product positioning.
• Market position: Healthcare robotics company focused on exoskeleton-assisted rehabilitation and mobility support.
• Adoption constraints: Adoption depends on clinical validation, safety, reimbursement, user comfort, therapist workflow fit, service support and cost.
• Adjacent context: Adjacent context includes rehabilitation exoskeletons, eldercare robotics, assistive mobility devices and clinical rehabilitation robots.
• Source confidence: medium

Events

• 2026-03-05 - Funding - Chengtian Technology completes B+ financing round - Chengtian Technology announced completion of a B+ financing round described as worth more than RMB 100 million.
• 2025-04-01 - Product Launch - Chengtian Technology (程天科技) launches EasyGo consumer exoskeleton and sells out first batch - Chengtian launched the EasyGo consumer exoskeleton product at a price of around RMB 2,500
• 2025-03-27 - Funding - Chengtian Technology (程天科技) completes near-RMB 100M Series B financing - Chengtian Technology announced completion of a near-RMB 100M Series B financing round
• 2021-03-30 - Funding - Chengtian Technology (程天科技) raises Round A financing - EqualOcean reported that Chengtian Technology obtained tens of millions of RMB in Round A financing

Team

• Wang Tian - Founder and CEO